This research study aims to see how well the study treatment, a drug-device combination performs as a possible treatment for diabetic peripheral neuropathic pain.
About this study
We are inviting adults to take part in this research trial aiming to reduce pain intensity for people with diabetic peripheral neuropathic pain.
The primary objective of the study is to evaluate the effectiveness of the study treatment via aerosol compared to placebo via the Syqe Fixed-dose Inhaler.
During the trial, participants will receive either study medicine or a placebo to be inhaled every day for up to 16 weeks.
This study is closed and no longer recruiting.
Ethics
All research in Australia involving human participants is reviewed by an independent group called a Human Research Ethics Committee (HREC). The ethical aspects of this research study have been approved by an Australian registered and certified HREC.
This study is being carried out according to the National Statement on Ethical Conduct in Human Research (2025). This statement protects the interests of people who agree to participate in human research studies.